Loading...

Cineplex Inc.

CGX.TOTSX
$11.27
$-0.10(-0.88%)
Canadian Market opens in 61h 0m

CGX.TO News Today: Stay Updated with the Latest Cineplex Inc. News in Real Time

Find CGX.TO news now at Meyka AI. Stay informed with the latest Cineplex Inc. stocks updates, including price news, market analysis, and expert insights.

2345.T Stock Plunges 30% on May 2, 2026 as Kushim Faces Losses
📅 in about 5 hours

2345.T Stock Plunges 30% on May 2, 2026 as Kushim Faces Losses

Kushim Inc. (2345.T) crashes 30% on JPX. Negative earnings, weak cash flow, and D+ rating signal deep trouble for the blockchain software firm.

Read more
BOMBF Bombardier Q1 2026 Earnings Beat EPS Estimate
📅 in about 5 hours

BOMBF Bombardier Q1 2026 Earnings Beat EPS Estimate

Bombardier Inc. (BOMBF) beat EPS estimate by 135.68% with $1.81 actual vs $0.77 expected, but missed revenue target slightly at $1.60B.

Read more
RDDT Reddit Q1 2026 Earnings Beat: EPS Surges 63%
📅 in about 5 hours

RDDT Reddit Q1 2026 Earnings Beat: EPS Surges 63%

Reddit Q1 2026 earnings beat expectations with $1.01 EPS vs $0.62 estimate and $663M revenue vs $607.7M forecast.

Read more
MTZ MasTec Earnings Beat: Q1 2026 Results Exceed Expectations
📅 in about 5 hours

MTZ MasTec Earnings Beat: Q1 2026 Results Exceed Expectations

MasTec (MTZ) Q1 2026 earnings beat estimates with $1.39 EPS and $3.83B revenue. Stock up 5.9% on strong infrastructure demand.

Read more
BDRBF Maintained: Analysts Raise Price Targets May 2026
📅 in about 4 hours

BDRBF Maintained: Analysts Raise Price Targets May 2026

Multiple analysts maintain ratings on Bombardier while raising price targets. Desjardins, RBC, CIBC, and BMO increase targets on May 1, 2026.

Read more
RSMDF ResMed Inc. Earnings Beat: Q1 2026 Results
📅 in about 4 hours

RSMDF ResMed Inc. Earnings Beat: Q1 2026 Results

ResMed Inc. (RSMDF) beat EPS estimates by 2.22% and revenue by 0.76% in Q1 2026 earnings report released April 30.

Read more
4564.T Stock Down 4.2% in Pre-Market: OncoTherapy Science Analysis
📅 in about 4 hours

4564.T Stock Down 4.2% in Pre-Market: OncoTherapy Science Analysis

4564.T drops 4.2% in pre-market trading. OncoTherapy Science stock analysis with volume surge and technical signals.

Read more
MLM Earnings Beat: Martin Marietta Q1 2026 Results
📅 in about 4 hours

MLM Earnings Beat: Martin Marietta Q1 2026 Results

Martin Marietta Materials beat EPS estimates by 8.43% and revenue by 3.74% in Q1 2026 earnings.

Read more
ALNY Earnings Beat: Alnylam Crushes Q1 2026 Estimates
📅 in about 4 hours

ALNY Earnings Beat: Alnylam Crushes Q1 2026 Estimates

Alnylam Pharmaceuticals (ALNY) crushed Q1 2026 earnings with EPS of $1.51 vs $0.90 estimate, up 68.72%. Revenue hit $1.17B, beating by 4.63%.

Read more

CGX.TO News FAQ